Delivery Order SPE2DB24D2100-SPE2DB24FBCPR
Award Date
7/25/24
Potential Completion Date
8/15/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,434.00 for the pharmaceutical product RHOPHYLAC 150MCG/ML 2S. The contract is with the Defense Logistics Agency (DLA), which is the Department of Defense's combat logistics support agency, and has a completion date of June 12, 2025. The contract is a Firm Fixed Price arrangement and is not set aside for any special categories of contractors. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.36 firm fixed-price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2022 and was awarded on September 28, 2022. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract, valued at $1,103.02, is a Delivery Order with a Firm Fixed Price pricing type awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 13, 2024 and was awarded on May 22, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award, valued at $2,295.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a performance period through April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division, with a ceiling value of $1,617.00, provides for the delivery of pharmaceutical products and medical supplies to support the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies to support the U.S. government's healthcare programs. The fixed-price delivery order, valued at $2,027.65, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of October 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts,...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of a diverse range of medical and pharmaceutical products. The contract is a Delivery Order with a Firm Fixed Price, valued at $2,343.24, and has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $10,238.80 for the supply of pharmaceutical and medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of April 30, 2024 and is a Firm Fixed Price agreement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $2,093.13 Firm Fixed Price Delivery Order for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of June 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,558.62 firm fixed-price delivery order is for the supply of various pharmaceutical products and medical supplies to support federal healthcare programs. The contract has an ultimate completion date of July 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with DLA and...